• A case of acquired thrombotic thrombocytopenic purpura following near-drowning
• A case of destination therapy for post-fulminant myocarditis with myelodysplastic syndrome
• A Case of Direct-Acting Oral Anticoagulant-Induced Intramural Colon Hematoma Successfully Treated by Laparoscopic Surgery
• A Case of Refractory Anemia in Patient of Chronic Kidney Disease and the Challenges in its Management
• Adolescent-onset epilepsy and deterioration associated with CAD deficiency: A case report
• AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review
• Anti-NMDA encephalitis secondary to an ovarian teratoma presenting as altered mental status in a 32-year-old woman: A case report
• ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study
• Autologous CD19- targeting CAR T cells in refractory juvenile dermatomyositis
• Avatrombopag as alternative therapy for severe aplastic anemia patients who are intolerant or unresponsive to eltrombopag
• Bardet-Biedl syndrome with unique manifestations of congenital giant nevi and refractory anemia: a case report from Palestine
• Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma
• Brucellosis-induced bilateral avascular necrosis of the hip joints in a middle-aged Iranian woman with refractory intolerance to medications: A case report
• Bruton's tyrosine kinase inhibitors in Refractory or Relapsing Primary Central Nervous System Lymphoma: A meta-analysis and systematic review
• Case report-unveiling a case of hemoglobin D-Punjab variant with iron deficiency anemia in Sindh (Pakistan)
• Case report: Blood-transfusion induced posterior reversible encephalopathy syndrome
• Case report: Ghosal hematodiaphyseal dysplasia-A rare cause of skeletal dysplasia and cytopenia
• Celiac Disease: A Forty-Year Analysis in an Italian Referral Center
• Chronic automated red cell exchange therapy for sickle cell disease
• Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 plus Imatinib for Advanced Treatment-refractory Gastrointestinal Stromal Tumors
• Clinical characteristics of human parvovirus B19 infection after allogeneic stem cell transplantation
• Clinical efficacy and safety of combined anti-BCMA and anti-CD19 CAR-T cell therapy for relapsed/refractory multiple myeloma: a systematic review and meta-analysis
• Clinical Efficacy and Safety of Ixazomib-Containing Regimens in the Treatment of Patients with Multiple Myeloma
• Clinical Spectrum of Celiac Disease among Adult Population: Experience from Largest Tertiary Care Hospital in Karachi, Pakistan
• Co-occurrence of collagenous gastrointestinal disease in siblings in early childhood: New insight into a rare condition
• Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
• Common design and data elements on rectal artery embolization for treatment of symptomatic internal hemorrhoidal disease: an interactive systematic review of clinical trials
• Cost-effectiveness of sutimlimab in cold agglutinin disease
• COVID-Induced Thrombotic Thrombocytopenic Purpura: A Case Report and Treatment-Focused Review
• Detection of Asymptomatic Sickle Cell Hemoglobin Carriers and Fetal Hemoglobin Regulating Genetic Variants in African Descendants from Oaxaca, Mexico
• Diagnosis and treatment of iron deficiency anemia
• Diagnostic and Therapeutic Strategies in Evans Syndrome: A Case Report and Literature Review
• Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series
• Efficacy and safety of gilteritinib-based combination therapy bridging allo-HSCT in relapsed or refractory acute myeloid leukemia patients with positive FLT3-ITD mutation
• Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
• Efficacy and safety of roxadustat in the treatment of refractory non-severe aplastic anemia
• Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies
• Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials
• Endovascular Treatment for Cerebral Venous Sinus Thrombosis: Comparison among Different Endovascular Procedures
• Exploring the Clinical and Hematological Characteristics of Beta-Thalassemia Trait: A Comprehensive Analysis in a Tertiary Care Hospital Setting
• Failure to Thrive With Severe Hypokalemia Yields Cystinosis Diagnosis in a 19-Month-Old Female Child: A Case Report
• Failure to Thrive, Metabolic Acidosis, and Diarrhea in a 7-Week-Old Infant
• First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC
• First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
• Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial
• From Alpha-Thalassemia Trait to <em>NPRL3</em>-Related Epilepsy: A Genomic Diagnostic Odyssey
• Gastric Antral Vascular Ectasia: Resolution of Bleeding and Stabilization of Hematocrit Following Orthotopic Liver Transplantation
• Giant cell hepatitis associated with autoimmune hemolytic anemia: More evidence for B-cell depletion therapy for a rare immune mediated disease of infancy
• Hematological Profile of Hb Adana Among High School Students in Northeast Peninsular Malaysia
• Ibrutinib and R-GemOx in patients with relapsed or refractory diffuse large B-cell lymphoma of non-GCB type: Phase II clinical trial of the Spanish GELTAMO group
• Immune Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, Therapy and Open Issues
• Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections
• Intermittent melena and refractory anemia due to jejunal cavernous lymphangioma: A case report
• Laboratory Testing for Celiac Disease: Clinical and Methodological Considerations
• LACC1 deficiency leading to juvenile arthritis and anemia
• Laparoscopic excision of accessory spleen for recurrent autoimmune hemolytic anemia after splenectomy: a case report
• Late-onset refractory hemolytic anemia in siblings treated for methionine synthase reductase deficiency: A rare complication possibly prevented by hydroxocobalamin dose escalation?
• Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
• Long-term follow-up of eltrombopag treatment for patients with cyclosporin A refractory/relapsed transfusion-dependent non-severe aplastic anemia: A report from a single center in China
• Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia
• Multiple autoimmune disorders refractory to glucocorticoids after allogeneic hematopoietic stem cell transplantation: a case report and review of the literature
• Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics
• Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome
• Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma
• Optimizing Perioperative Care for Ventricular Tachycardia Ablation in High-Risk Patients Supported by Impella 5.5
• Penile prosthesis in priapism: a systematic review of outcomes and complications
• Phase 1 study of azacitidine in combination with quizartinib in patients with FLT3 or CBL mutated MDS and MDS/MPN
• Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarnib for Relapsed/Refractory Peripheral T Cell Lymphoma
• Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma
• Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma
• Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer
• Recombinant erythropoietin for the treatment of iron deficiency anemia in pregnancy: A systematic review
• Refractory autoimmune hemolytic anemia in a patient with systemic lupus erythematosus and ulcerative colitis: A case report
• Refractory hypoxia and saturation gap in a COVID-19 patient
• Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib
• Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide
• Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis: Case report
• Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic Syndrome
• Ruxolitinib for pediatric patients with treatment-naive and steroid-refractory acute graft-versus-host disease (REACH4)
• Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial
• Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis
• Salvage treatment of ruxolitinib for refractory adenovirus-associated hemophagocytic syndrome post-haploidentical allogeneic stem cell transplantation: a case report
• Severe BCG immune reconstitution inflammatory syndrome lymphadenitis successfully managed with pre-antiretroviral counseling and a non-surgical approach: a case report
• Severe, Refractory Primary Warm Autoimmune Hemolytic Anemia Requiring 90 Erythrocyte Transfusions
• Social defeat stress impairs systemic iron metabolism by activating the hepcidin-ferroportin axis
• Structural screening and molecular simulation identify potential ligands against the K700E hot spot variant and functional pockets of SF3B1 to modulate splicing in myelodysplastic syndrome
• Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review
• Target trial emulation of carfilzomib safety among patients with relapsed/refractory multiple myeloma using a nationwide observational data in Korea
• The 505th case: refractory ascites and monoclonal immunoglobulin
• The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease
• The treatment strategies of autoimmune hemolytic anemia
• Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial
• Treating Parvovirus Triggered Refractory Hemolytic Anemia with Rituximab in Renal Transplant Recipients - A Report of Two Cases
• Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study
• Treatment of relapsed/refractory chronic lymphocytic leukemia with Zanubrutinib after progressing on other BTK inhibitors
• Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations
• Two-step versus three-step proctocolectomy for ulcerative colitis: a comparative study on nutritional status, immunosuppressive therapy, and long-term outcome
• Uncommon Manifestation: Thrombotic Thrombocytopenic Purpura Presenting Solely as Petechial Rash
• Unveiling the Unlikely: Extraskeletal Ewing Sarcoma Masquerading as Gastrointestinal Bleeding
• Waldenström macroglobulinemia: a challenging case treated with anti-CD19 CAR-T cell therapy